病例报告：F-PSMA-1007 PET/CT检测到的去势抵抗性前列腺癌孤立性阴茎转移，前列腺特异性抗原（PSA）为0.072 ng/ml 。
Case Report: F-PSMA-1007 PET/CT Avid Solitary Penile Metastasis of Castration-Resistant Prostate Cancer With a PSA of 0.072 ng/ml.
作者信息
Li Yongliang, Li Yanmei, Dong Siying, Chen Jian, Yang Pengfei, Li Juan
机构信息
Department of Nuclear Medicine, General Hospital of Ningxia Medical University, Yinchuan, China.
School of Clinical Medicine, Ningxia Medical University, Yinchuan, China.
出版信息
Front Oncol. 2022 Apr 20;12:881896. doi: 10.3389/fonc.2022.881896. eCollection 2022.
Penile metastasis of prostate cancer is rare, with a poor prognosis, and only a limited number of relevant cases have been reported so far. With the application of F-PSMA-1007 PET/CT, the biochemical recurrence of prostate cancer can be detected at an early stage for providing important evidence, facilitating clinical decision-making. Here, we have reported a case of solitary penile metastatic recurrence in the context of mild PSA progression (PSA: 0.072 ng/ml). This case highlights the preferable sensitivity of F-PSMA-1007 PET/CT imaging in prostate cancer.
前列腺癌的阴茎转移罕见，预后较差，目前仅有有限数量的相关病例报道。随着F-PSMA-1007 PET/CT的应用，可早期检测前列腺癌的生化复发，为临床决策提供重要依据。在此，我们报告了1例在前列腺特异抗原（PSA）轻度进展（PSA：0.072 ng/ml）情况下发生孤立性阴茎转移复发的病例。该病例凸显了F-PSMA-1007 PET/CT成像在前列腺癌中具有较好的敏感性。
Zotero 插件